跳至主要内容
临床试验/CTRI/2024/10/075551
CTRI/2024/10/075551尚未招募3 期

Prospective controlled clinical study to evaluate the efficacy of Brihat Dashmoola Taila Nasya in Ardhavabhedaka with special reference to Migraine

Dr Neha Vivekanand Ladvikar1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2024年10月25日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
72
试验地点
1
主要终点
Relief in migraine pain

研究概览

简要总结

Current study is based on the ayurvedic approach in the management of Ardhavabhedaka  with special reference to Migraine using MIDAS score. Sample size is 72. Improvement in symptoms of Ardhavabhedaka and reduction in MIDAS score will be evaluated. Two groups are selected group A and group B. In group A  patients will be treated with Brihat Dashmool Taila Nasya for 15 days and in group B patients will be treated with  Anu Taila Nasya for 15 days and symptommatic relief and depletion in MIDAS score will be calculated.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
15.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients suffering from signs and symptoms oF Ardhavabhedaka for more than 3 months Ardhaparshwa (Unilateral) Shoola (Pulsating throbbing type of pain) Pakshat Dashahat Akasmat (Paroxysmal) Prakasha Asahishnuta (Photophobia) Shabdaasahishnuta ( phonophobia) Patients Arha for NasyaKarma fit for Nasya Karma MIDAS score greater than or equal to 6.

排除标准

  • Patients suffering from chronic debilitating disease with other neurological pathology E.N.T. and opthalmic pathology referred pain meningitis sepsis and requiring surgical intervention Patients Anaharyafor Nasya Karma or contraindicated for Nasya Karma Patients suffering from psychiatric pathology Pregnant and lactating women Patients using any other systemic drug that may alter the results of study.

结局指标

主要结局

Relief in migraine pain

时间窗: 15 days

次要结局

  • Decrease in MIDAS score(15 days)

研究者

发起方
Dr Neha Vivekanand Ladvikar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Neha Vivekanand Ladvikar

Ayurved Seva Sangha Ayurved Mahavidyalaya,Nashik

研究点 (1)

Loading locations...

相似试验